Midazolam Injection bulk supplier for pharma manufacturers

Midazolam Injection 1 mg/mL, 5 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injectable solution (IV/IM)

Available Strengths: 1 mg/mL, 5 mg/mL

Reference Brands: Versed(US); Epistatus(EU)

Midazolam is a benzodiazepine used for sedation, anesthesia, and seizure management. Available in injectable, nasal, and oral forms, it's marketed as Versed in the US and Buccolam in the EU. A critical ICU and emergency drug, Midazolam is a key product for pharma B2B distributors and hospital suppliers.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Midazolam is a fast-acting benzodiazepine used for sedation, anesthesia induction, and seizure control. Available in various forms like injections (1 mg/mL, 5 mg/mL), oral syrup, nasal spray, and buccal solutions, it is widely used in ICU and emergency settings. In the US, it is marketed under brands like Versed and Nayzilam, while in the EU, Buccolam and Epistatus are common. Midazolam is a high-demand product in hospital and ambulatory care, making it a vital listing for pharmaceutical B2B platforms dealing in anesthesia, emergency care, and neurology segments.

Midazolam Injection — third party manufacturing & bulk supply

Midazolam Injection 1 mg/mL, 5 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Midazolam Injection is supplied as Injectable solution (IV/IM) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Midazolam Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Midazolam Injection →

Back to Listing

Frequently Asked Questions

Midazolam injection is used for sedation, induction of anesthesia, and procedural sedation in adults and pediatric patients. It is commonly administered before surgical or diagnostic procedures to reduce anxiety and produce amnesia. It is also used in intensive care units for continuous sedation and in emergency settings for the management of status epilepticus.

Midazolam injection is made from midazolam hydrochloride, a short-acting benzodiazepine. It works by enhancing the effect of gamma-aminobutyric acid (GABA) in the central nervous system, producing sedative, anxiolytic, muscle-relaxant, and anticonvulsant effects.

The trade names include Versed and Epistatus. Versed is commonly marketed for injectable use, while Epistatus is primarily marketed as an oromucosal (buccal) solution for seizure management in certain regions.

Versed was originally developed and marketed by Roche and is now manufactured or distributed by various pharmaceutical companies depending on the country. Epistatus is marketed by Special Products Ltd in the United Kingdom.

The generic name is midazolam hydrochloride.

Brand names include Versed and Epistatus.

Midazolam injection is manufactured in GMP-certified pharmaceutical facilities in multiple countries including the United States, European Union, and other regions, depending on the marketing authorization holder and supplier. Specific manufacturing sites vary by brand and batch.